MARVECS GmbH provides marketing and sales services for healthcare companies, specifically pharmaceutical manufacturers, OTC providers and medical technology firms. Its offering includes vacancy management, exclusive service teams, partnering teams, patient support programs and comprehensive multi-channel measures including digital solutions. Since March 2024 it additionally took over the pharmacy distribution of Cesra Arzneimittel GmbH & Co. KG including logistics, after receiving the wholesale permit on 13.12.2023. The sole shareholder is Mondstein 318. GmbH; MARVECS owns a 100% subsidiary (SANTIS) and 60% of Palgos GmbH (resolution to dissolve as of 31.12.2024).
Erbringung von Dienstleistungen in Marketing und Vertrieb im pharmazeutischen Bereich sowie der Handel und Vertrieb von Arzneimitteln- und Kosmetikprodukten mit einer Großhandelserlaubnis, sowie alle damit verbundenen Geschäftsvorgänge.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 3810 (as of 20 September 2026)
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 3810 (as of 20 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 3810 (as of 20 September 2026)
Sign in to view detailed salary and cost trends.
